Tag: Antibiotic Resistance
-

Superbug Candida auris spreads to 28 states, Alabama among cases
Overview: A rising threat from a drug‑resistant fungus A troubling fungal “superbug” is expanding its reach across the United States. Candida auris, a yeast that can cause severe infections, is resistant to many common antifungal medicines. Health officials say the organism has been identified in 28 states this year, with Alabama reporting 158 cases so…
-

Superbug Spreads Across 28 States: How Candida auris Is Reaching Alabama and Beyond
Overview: A Antibiotic-Resistant Fungus on the Rise A dangerous, drug-resistant fungus is expanding its reach across the United States, with Alabama reporting a notable surge in cases. Candida auris, a yeast that can cause serious infections in healthcare settings, has emerged as a nationwide concern. Health authorities confirm rising case numbers as facilities confront the…
-

Superbug Spread: Candida Auris Hits 28 States, Alabama Contends with 158 Cases
What is Candida auris and why it matters Candida auris is a yeast-like fungus that can cause serious bloodstream infections, wound infections, and invasive illnesses—especially in people with weakened immune systems. What makes C. auris particularly alarming is its resistance to multiple antifungal drugs and its ability to spread in healthcare settings, including hospitals and…
-

How Tiny RNA Helpers in Phages Boost Bacterial Hijacking and Phage Replication
Introduction: A Tiny RNA, Big Impact As antibiotic resistance climbs, scientists are turning to bacteriophages—viruses that infect bacteria—as potential allies in the fight against hard-to-treat infections. A recent study uncovers a surprising mechanism: phages use a small RNA molecule to hijack bacterial cells, rewiring their machinery to favor phage replication. This discovery adds a new…
-

How Phages Use Tiny RNA to Hijack Bacteria and Boost Replication
Introduction: A New Dimension in Phage Therapy As antibiotic-resistant infections threaten global health, researchers are turning to bacteriophages—viruses that infect bacteria—as a potential alternative or supplement to conventional antibiotics. A recent study has shed light on a surprising mechanism: bacteriophages using a tiny piece of RNA to hijack bacterial cellular machinery and boost their own…
-

New Antibiotics hailed as a Turning Point in Treating Drug-Resistant Gonorrhoea
Hope on the horizon as new antibiotics reach the fight against gonorrhoea Medical researchers are calling a recent breakthrough in antibiotics a potential turning point in the long struggle against drug-resistant gonorrhoea. The sexually transmitted infection has shown a worrying ability to adapt, outpacing many standard treatments and driving global concerns about the rise of…
-

Antibiotic resistance: how a pioneering trial is using old drugs to save babies from sepsis
New hope for newborns in a warm coastal town Just minutes from the turquoise waters of Kilifi Creek, a team of clinicians, microbiologists and technicians is rewriting how we treat neonatal sepsis. In a region where antibiotic resistance threatens to outpace medical advances, the NeoSep1 trial is testing whether familiar, older antibiotics can save vulnerable…
-

Old Drugs, New Hope: How a Pioneering Trial Uses Familiar Antibiotics to Save Babies from Sepsis
Introduction: A quiet revolution in neonatal care In a sunlit clinic near Kenya’s Kilifi Creek, a team of clinicians, microbiologists, and researchers is tackling one of medicine’s toughest challenges: sepsis in newborns. The NeoSep1 trial is testing a bold idea—using older, well-known antibiotics in new combinations to outpace resistance and improve survival for some of…
-

WHO Alarm as Drug-Resistant Gonorrhoea Surges: Urgent Action Needed
WHO Warns: A Rapid Rise in Drug-Resistant Gonorrhoea The World Health Organisation (WHO) has issued a stark warning about a sharp increase in drug-resistant gonorrhoea, a sexually transmitted infection that is becoming harder to treat as antibiotic resistance tightens its grip. With resistance to ciprofloxacin now estimated at about 95% globally, researchers and public health…
-

Study Highlights Colonization and Spread of Resistant Bacteria in NICUs
Overview Recent research shines a light on how resistant bacteria establish themselves in neonatal intensive care units (NICUs) and how they spread between patients and surfaces. The findings underscore the ongoing struggle against antimicrobial resistance (AMR) in one of the most vulnerable patient populations: newborns. Understanding colonization dynamics in NICUs is essential for improving infection…
